Temat: "SARS-CoV-2" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Visualization of Early RNA Replication Kinetics of SARS-CoV-2 by Using Single Molecule RNA-FISH Combined with Immunofluorescence.
Autorzy:: Pathak R; Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Eliscovich C; Department of Medicine (Hepatology), Albert Einstein College of Medicine, Bronx, NY 10461, USA.; Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Mena I; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Cupic A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Rutkowska M; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Jangra RK; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Singer RH; Departments of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.; Departments of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Kalpana GV; Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 07; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/genetics
SARS-CoV-2*/metabolism
COVID-19*/metabolism
Humans ; RNA Replication ; In Situ Hybridization, Fluorescence/methods ; Reactive Oxygen Species/metabolism ; Subgenomic RNA ; RNA, Guide, CRISPR-Cas Systems ; Fluorescent Antibody Technique ; Proteins/metabolism ; RNA, Viral/genetics ; RNA, Viral/metabolism
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Comprehensive genomic analysis of the SARS-CoV-2 Omicron variant BA.2.76 in Jining City, China, 2022.
Autorzy:: Yin Q; Department of Laboratory, Jining Center for Disease Control and Prevention, Jining, China.
Liu W; Department of Laboratory, Jining Center for Disease Control and Prevention, Jining, China.
Jiang Y; Department of Laboratory, Jining Center for Disease Control and Prevention, Jining, China.
Feng Q; Department of Laboratory, Rencheng Center for Disease Control and Prevention, Jining, China.
Wang X; Department of Laboratory, Jining Center for Disease Control and Prevention, Jining, China.
Dou H; Department of Laboratory, Jining Center for Disease Control and Prevention, Jining, China.
Liu Z; Department of Laboratory, Jining Center for Disease Control and Prevention, Jining, China.
He F; Computer Information Technology, Northern Arizona University, Arizona, USA.
Fan Y; Department of Laboratory, Jining Center for Disease Control and Prevention, Jining, China. .
Jiao B; Department of Medicine, School of Medicine, University of Connecticut Health Center, Farmington, CT, USA. .
Jiao B; Department of Laboratory, Jining Center for Disease Control and Prevention, Jining, China. .; Pokaż więcej
Źródło:: BMC genomics [BMC Genomics] 2024 Apr 17; Vol. 25 (1), pp. 378. Date of Electronic Publication: 2024 Apr 17.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*
COVID-19*
Humans ; Pandemics ; Genomics ; China ; Amino Acids ; Nucleotides
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Ursodeoxycholic acid may protect from severe acute respiratory syndrome coronavirus 2 Omicron variant by reducing angiotensin-converting enzyme 2.
Autorzy:: Lee K; Pharmaceutical Technology Center, Daewoong Pharmaceutical Co., Ltd, Yongin-si, Gyeonggi-do, Republic of Korea.; College of Pharmacy, Pusan National University, Busan, Republic of Korea.
Na Y; Pharmaceutical Technology Center, Daewoong Pharmaceutical Co., Ltd, Yongin-si, Gyeonggi-do, Republic of Korea.
Kim M; Drug Discovery Center, Daewoong Pharmaceutical Co., Ltd, Yongin-si, Gyeonggi-do, Republic of Korea.
Lee D; Pharmaceutical Technology Center, Daewoong Pharmaceutical Co., Ltd, Yongin-si, Gyeonggi-do, Republic of Korea.
Choi J; Pharmaceutical Technology Center, Daewoong Pharmaceutical Co., Ltd, Yongin-si, Gyeonggi-do, Republic of Korea.
Kim G; Pharmaceutical Technology Center, Daewoong Pharmaceutical Co., Ltd, Yongin-si, Gyeonggi-do, Republic of Korea.
Kim MS; College of Pharmacy, Pusan National University, Busan, Republic of Korea.; Pokaż więcej
Źródło:: Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Apr; Vol. 12 (2), pp. e1194.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*
COVID-19*
Animals ; Cricetinae ; Humans ; Ursodeoxycholic Acid/pharmacology ; Ursodeoxycholic Acid/therapeutic use ; Angiotensin-Converting Enzyme 2/genetics ; Pandemics
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Bus Riding as Amplification Mechanism for SARS-CoV-2 Transmission, Germany, 2021 .
Autorzy:: Schöll M
Höhn C
Boucsein J
Moek F
Plath J
An der Heiden M
Huska M
Kröger S
Paraskevopoulou S
Siffczyk C
Buchholz U
Lachmann R; Pokaż więcej
Źródło:: Emerging infectious diseases [Emerg Infect Dis] 2024 Apr; Vol. 30 (4), pp. 711-720.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*
COVID-19*/epidemiology
Child ; Humans ; Cohort Studies ; Disease Outbreaks ; Germany/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor.
Autorzy:: Trepte P; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany. .; Brain Development and Disease, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030, Vienna, Austria. .
Secker C; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany. .; Zuse Institute Berlin, Berlin, Germany. .
Olivet J; Laboratory of Viral Interactomes, Interdisciplinary Cluster for Applied Genoproteomics (GIGA)-Molecular Biology of Diseases, University of Liège, 4000, Liège, Belgium.; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Structural Biology Unit, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, Katholieke Universiteit Leuven, 3000, Leuven, Belgium.
Blavier J; Laboratory of Viral Interactomes, Interdisciplinary Cluster for Applied Genoproteomics (GIGA)-Molecular Biology of Diseases, University of Liège, 4000, Liège, Belgium.
Kostova S; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Maseko SB; Laboratory of Viral Interactomes, Interdisciplinary Cluster for Applied Genoproteomics (GIGA)-Molecular Biology of Diseases, University of Liège, 4000, Liège, Belgium.
Minia I; RNA Biology and Posttranscriptional Regulation, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, 13125, Berlin, Germany.
Silva Ramos E; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Cassonnet P; Département de Virologie, Unité de Génétique Moléculaire des Virus à ARN (GMVR), Institut Pasteur, Centre National de la Recherche Scientifique (CNRS), Université de Paris, Paris, France.
Golusik S; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Zenkner M; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Beetz S; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Liebich MJ; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Scharek N; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Schütz A; Protein Production & Characterization, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany.
Sperling M; Multifunctional Colloids and Coating, Fraunhofer Institute for Applied Polymer Research (IAP), 14476, Potsdam-Golm, Germany.
Lisurek M; Structural Chemistry and Computational Biophysics, Leibniz-Institut für Molekulare Pharmakologie (FMP), 13125, Berlin, Germany.
Wang Y; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Spirohn K; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Hao T; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Calderwood MA; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Hill DE; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Landthaler M; RNA Biology and Posttranscriptional Regulation, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, 13125, Berlin, Germany.; Institute of Biology, Humboldt-Universität zu Berlin, 13125, Berlin, Germany.
Choi SG; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA. .; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA. .; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. .
Twizere JC; Laboratory of Viral Interactomes, Interdisciplinary Cluster for Applied Genoproteomics (GIGA)-Molecular Biology of Diseases, University of Liège, 4000, Liège, Belgium. .; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA. .; TERRA Teaching and Research Center, Gembloux Agro-Bio Tech, University of Liège, 5030, Gembloux, Belgium. .; Laboratory of Algal Synthetic and Systems Biology, Division of Science and Math, New York University Abu Dhabi, Abu Dhabi, UAE. .
Vidal M; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, MA, 02215, USA. marc_.; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA. marc_.
Wanker EE; Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125, Berlin, Germany. .; Pokaż więcej
Źródło:: Molecular systems biology [Mol Syst Biol] 2024 Apr; Vol. 20 (4), pp. 428-457. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/metabolism
COVID-19*
Humans ; Methyltransferases/metabolism ; Artificial Intelligence ; Drug Discovery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model.
Autorzy:: Tan B; Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Zhang X; Department Physiological Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA.
Ansari A; Center for Advanced Biotechnology and Medicine, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.; Department of Chemistry and Chemical Biology, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Jadhav P; Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Tan H; Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Li K; Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Chopra A; Center for Advanced Biotechnology and Medicine, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.; Department of Chemistry and Chemical Biology, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Ford A; Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA.
Chi X; Department Physiological Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA.
Ruiz FX; Center for Advanced Biotechnology and Medicine, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.; Department of Chemistry and Chemical Biology, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Arnold E; Center for Advanced Biotechnology and Medicine, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.; Department of Chemistry and Chemical Biology, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Deng X; Department Physiological Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA.; Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, OK 74078, USA.
Wang J; Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2024 Mar 29; Vol. 383 (6690), pp. 1434-1440. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Journal Article
MeSH Terms:: Coronavirus Papain-Like Proteases*/antagonists & inhibitors
Coronavirus Papain-Like Proteases*/chemistry
COVID-19*
SARS-CoV-2*/drug effects
SARS-CoV-2*/enzymology
Coronavirus Protease Inhibitors*/administration & dosage
Coronavirus Protease Inhibitors*/chemistry
Coronavirus Protease Inhibitors*/pharmacology
Drug Design*
COVID-19 Drug Treatment*
Animals ; Mice ; Disease Models, Animal ; Administration, Oral ; Crystallography, X-Ray ; Structure-Activity Relationship ; Viral Load/drug effects ; Male ; Mice, Inbred C57BL ; Mice, Inbred BALB C
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: The symptoms and interval of Omicron SARS-CoV-2 reinfection among healthcare workers in a hospital of Southern China: a cross-sectional study.
Autorzy:: Ma X; Department of Hospital Acquired Infection Control and Public Health Management, The Seventh Affiliated Hospital, Sun Yat-sen University, No.628 Zhenyuan Road, 518107, Shenzhen, Guangdong, China.
Wang Z; Department of Hospital Acquired Infection Control and Public Health Management, The Seventh Affiliated Hospital, Sun Yat-sen University, No.628 Zhenyuan Road, 518107, Shenzhen, Guangdong, China.
Chen Y; Department of Hospital Acquired Infection Control and Public Health Management, The Seventh Affiliated Hospital, Sun Yat-sen University, No.628 Zhenyuan Road, 518107, Shenzhen, Guangdong, China. .; Department of Infectious Diseases, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China. .
Li Z; Department of Infection Control, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, 210029, Nanjing, Jiangsu, China. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 27; Vol. 24 (1), pp. 354. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*
COVID-19*/epidemiology
Humans ; Female ; Male ; Cross-Sectional Studies ; COVID-19 Vaccines ; Reinfection/epidemiology ; Hospitals ; Fever ; Health Personnel
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Development and Evaluation of an In-House Real-Time RT-PCR Targeting nsp10 Gene for SARS-CoV-2 Detection.
Autorzy:: Yip CC; Department of Microbiology, Queen Mary Hospital, Hong Kong SAR, China.
Poon JH; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Leung KH; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Chan WM; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Ip JD; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Chu AW; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Cheng VC; Department of Microbiology, Queen Mary Hospital, Hong Kong SAR, China.
Yuen KY; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
To KK; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 21; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/genetics
COVID-19*/diagnosis
Humans ; Reverse Transcriptase Polymerase Chain Reaction ; COVID-19 Testing ; Sensitivity and Specificity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Design, Synthesis, and Biological Evaluation of Novel Coumarin Analogs Targeted against SARS-CoV-2.
Autorzy:: Sharma K; Chitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India.
Singh M; Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
Sharma P; Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
Sharma SC; Chitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India.
Mujwar S; Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
Kapoor M; Chitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India.
Mishra KK; Chitkara Institute of Engineering and Technology, Chitkara University, Rajpura 140401, Punjab, India.
Wani TA; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2024 Mar 21; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*
COVID-19*
Humans ; Coumarins/pharmacology ; Biological Assay ; Ketones ; Antiviral Agents/pharmacology ; Molecular Docking Simulation ; Protease Inhibitors ; Molecular Dynamics Simulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Assessing the Clinical Impact of the SARS-CoV-2 Gamma Variant on Intensive Care Unit Admissions: Insights from a Reference Hospital in Northeastern Brazil.
Autorzy:: Nonaka CKV; D'Or Institute for Research and Education (IDOR), Salvador 41253-190, BA, Brazil.; São Rafael Hospital, Salvador 41253-190, BA, Brazil.
de Jesus Ribeiro AM; Institute of Health Sciences, Federal University of Bahia, Salvador 40231-300, BA, Brazil.
Rocha GV; D'Or Institute for Research and Education (IDOR), Salvador 41253-190, BA, Brazil.; Gonçalo Moniz Institute, FIOCRUZ, Salvador 40296-710, BA, Brazil.
da Hora HS; Institute of Health Sciences, Federal University of Bahia, Salvador 40231-300, BA, Brazil.
Junior AAF; National Agropecuary Laboratory, MAPA, Pedro Leopoldo 33250-220, MG, Brazil.
Lima FM; Bahiana School of Medicine Salvador, Salvador 40290-000, BA, Brazil.
Bastos IN; Faculty of Medicine and Dentistry, Federal University of Bahia, Salvador 40110-100, BA, Brazil.
Teles SAS; São Rafael Hospital, Salvador 41253-190, BA, Brazil.
Weber TGL; São Rafael Hospital, Salvador 41253-190, BA, Brazil.
Costa VF; São Rafael Hospital, Salvador 41253-190, BA, Brazil.
Costa-Ferro ZS; D'Or Institute for Research and Education (IDOR), Salvador 41253-190, BA, Brazil.
Rocha CAG; D'Or Institute for Research and Education (IDOR), Salvador 41253-190, BA, Brazil.; Gonçalo Moniz Institute, FIOCRUZ, Salvador 40296-710, BA, Brazil.; Faculty of Medicine and Dentistry, Federal University of Bahia, Salvador 40110-100, BA, Brazil.
Sardi SI; Institute of Health Sciences, Federal University of Bahia, Salvador 40231-300, BA, Brazil.
Soares G; Institute of Health Sciences, Federal University of Bahia, Salvador 40231-300, BA, Brazil.
Mendes AVA; São Rafael Hospital, Salvador 41253-190, BA, Brazil.
Souza BSF; D'Or Institute for Research and Education (IDOR), Salvador 41253-190, BA, Brazil.; São Rafael Hospital, Salvador 41253-190, BA, Brazil.; Gonçalo Moniz Institute, FIOCRUZ, Salvador 40296-710, BA, Brazil.; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Rua Waldemar Falcão, 121, Salvador 40296-710, BA, Brazil.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 20; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: SARS-CoV-2*/genetics
COVID-19*/epidemiology
Adult ; Humans ; Brazil/epidemiology ; Pandemics ; Retrospective Studies ; Hospitals ; Hospitalization ; Intensive Care Units
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Predicting Vaccine Effectiveness for Hospitalization and Symptomatic Disease for Novel SARS-CoV-2 Variants Using Neutralizing Antibody Titers.
Autorzy:: Gardner BJ; Department of Ecology and Evolutionary Biology, University of California, Santa Cruz, CA 95060, USA.
Kilpatrick AM; Department of Ecology and Evolutionary Biology, University of California, Santa Cruz, CA 95060, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 20; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/genetics
COVID-19*/prevention & control
Humans ; Vaccine Efficacy ; BNT162 Vaccine ; Hospitalization ; Antibodies, Neutralizing ; Antibodies, Viral
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Immune System Deficiencies Do Not Alter SARS-CoV-2 Evolutionary Rate but Favour the Emergence of Mutations by Extending Viral Persistence.
Autorzy:: Manuto L; Department of Molecular Medicine, DMM, University of Padova, 35121 Padova, Italy.
Bado M; Department of Molecular Medicine, DMM, University of Padova, 35121 Padova, Italy.
Cola M; Department of Medicine, DIMED, University of Padova, 35128 Padova, Italy.
Vanzo E; Department of Molecular Medicine, DMM, University of Padova, 35121 Padova, Italy.
Antonello M; Department of Molecular Medicine, DMM, University of Padova, 35121 Padova, Italy.
Mazzotti G; Department of Molecular Medicine, DMM, University of Padova, 35121 Padova, Italy.
Pacenti M; Unit of Microbiology and Virology, University Hospital of Padova, 35128 Padova, Italy.
Cordioli G; Department of Molecular Medicine, DMM, University of Padova, 35121 Padova, Italy.
Sasset L; Unit of Infectious Diseases, University Hospital of Padova, 35128 Padova, Italy.
Cattelan AM; Department of Molecular Medicine, DMM, University of Padova, 35121 Padova, Italy.; Unit of Infectious Diseases, University Hospital of Padova, 35128 Padova, Italy.
Toppo S; Department of Molecular Medicine, DMM, University of Padova, 35121 Padova, Italy.
Lavezzo E; Department of Molecular Medicine, DMM, University of Padova, 35121 Padova, Italy.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 13; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/genetics
COVID-19*
Humans ; Pandemics ; Mutation ; Quasispecies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Remote surveillance and detection of SARS-CoV-2 transmission among household members in King County, Washington.
Autorzy:: Emanuels A; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, UW Medicine Box 358061, Chu Lab Room E630, 750 Republican Street, Seattle, WA, 98109, USA.
Casto AM; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, UW Medicine Box 358061, Chu Lab Room E630, 750 Republican Street, Seattle, WA, 98109, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Heimonen J; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, UW Medicine Box 358061, Chu Lab Room E630, 750 Republican Street, Seattle, WA, 98109, USA.
O'Hanlon J; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, UW Medicine Box 358061, Chu Lab Room E630, 750 Republican Street, Seattle, WA, 98109, USA.
Chow EJ; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, UW Medicine Box 358061, Chu Lab Room E630, 750 Republican Street, Seattle, WA, 98109, USA.
Ogokeh C; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Rolfes MA; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Han PD; Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
Hughes JP; Department of Biostatistics, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Uyeki TM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Frazar C; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
Chung E; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, UW Medicine Box 358061, Chu Lab Room E630, 750 Republican Street, Seattle, WA, 98109, USA.
Starita LM; Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.
Englund JA; Seattle Children's Research Institute, Seattle, Washington, USA.
Chu HY; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, UW Medicine Box 358061, Chu Lab Room E630, 750 Republican Street, Seattle, WA, 98109, USA. .; Pokaż więcej
Corporate Authors:: Seattle Flu Study Investigators
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 13; Vol. 24 (1), pp. 309. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:: Clinical Trial; Journal Article
MeSH Terms:: COVID-19*/diagnosis
COVID-19*/epidemiology
SARS-CoV-2*/genetics
Humans ; Pandemics ; Quarantine ; Washington/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic Workflows.
Autorzy:: Connor R; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
Shakya M; Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Yarmosh DA; American Type Culture Collection, Manassas, VA 20110, USA.; BEI Resources, Manassas, VA 20110, USA.
Maier W; Galaxy Europe Team, University of Freiburg, 79085 Freiburg, Germany.
Martin R; Clinical Virology Department, Gilead Sciences, Foster City, CA 94404, USA.
Bradford R; American Type Culture Collection, Manassas, VA 20110, USA.; BEI Resources, Manassas, VA 20110, USA.
Brister JR; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
Chain PSG; Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Copeland CA; Deloitte Consulting LLP, Rosslyn, VA 22209, USA.
di Iulio J; Vir Biotechnology Inc., San Francisco, CA 94158, USA.
Hu B; Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Ebert P; Eli Lilly and Company, Indianapolis, IN 46225, USA.
Gunti J; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
Jin Y; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
Katz KS; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
Kochergin A; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
LaRosa T; Deloitte Consulting LLP, Rosslyn, VA 22209, USA.
Li J; Clinical Virology Department, Gilead Sciences, Foster City, CA 94404, USA.
Li PE; Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Lo CC; Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Rashid S; American Type Culture Collection, Manassas, VA 20110, USA.
Maiorova ES; Clinical Virology Department, Gilead Sciences, Foster City, CA 94404, USA.
Xiao C; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
Zalunin V; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
Purcell L; Vir Biotechnology Inc., San Francisco, CA 94158, USA.
Pruitt KD; National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 11; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/genetics
COVID-19*/epidemiology
Humans ; Pandemics ; Workflow ; Computational Biology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Evaluation of the Polysaccharide "Immeran" Activity in Syrian hamsters' Model of SARS-CoV-2.
Autorzy:: Generalova LV; Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia.
Laryushkin DP; Federal Research Center 'Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences', Institute of Cell Biophysics of the Russian Academy of Sciences, 142290 Pushchino, Russia.
Leneva IA; Mechnikov Research Institute of Vaccines and Sera, Department of Virology, 105064 Moscow, Russia.
Ivanina AV; Mechnikov Research Institute of Vaccines and Sera, Department of Virology, 105064 Moscow, Russia.
Trunova GV; Federal State Budgetary Institution National Medical Research Radiological Center (FSBI NMRRC) of the Ministry of Health of the Russian Federation, P.A. Hertsen Moscow, Oncology Research Institute, 125284 Moscow, Russia.
Dolinnyi SV; Faculty of Medicine, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia.
Generalov EA; Faculty of Physics, Lomonosov Moscow State University, 119991 Moscow, Russia.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 09; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*
COVID-19*
Cricetinae ; Animals ; Humans ; Mesocricetus ; Prospective Studies ; Lung ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Disease Models, Animal ; Antibodies, Neutralizing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.
Autorzy:: Clever S; Institute of Virology, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hanover, Germany.
Limpinsel L; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.
Meyer Zu Natrup C; Institute of Virology, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hanover, Germany.
Schünemann LM; Institute of Virology, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hanover, Germany.
Beythien G; Department of Pathology, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hanover, Germany.
Rosiak M; Department of Pathology, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hanover, Germany.
Hülskötter K; Department of Pathology, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hanover, Germany.
Gregor KM; Department of Pathology, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hanover, Germany.
Tuchel T; Institute of Virology, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hanover, Germany.
Kalodimou G; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.
Freudenstein A; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.
Kumar S; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.
Baumgärtner W; Department of Pathology, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hanover, Germany.
Sutter G; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.
Tscherne A; Division of Virology, Department of Veterinary Sciences, LMU Munich, 85764 Oberschleißheim, Germany.
Volz A; Institute of Virology, University of Veterinary Medicine Hannover, Buenteweg 17, 30559 Hanover, Germany.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 08; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/genetics
COVID-19*/prevention & control
gamma-Globulins*
Melphalan*
Viral Vaccines*
Vaccines, DNA*
Animals ; Humans ; Mice ; COVID-19 Vaccines ; Antibodies, Viral ; Spike Glycoprotein, Coronavirus/genetics ; Vaccination ; Antibodies, Neutralizing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Unraveling the genetic variations underlying virulence disparities among SARS-CoV-2 strains across global regions: insights from Pakistan.
Autorzy:: Jabeen M; National Center for Bioinformatics, Program of Comparative and Evolutionary Genomics, Faculty of Biological Sciences, Quaid-i-Azam University, 45320, Islamabad, Pakistan.
Shoukat S; National Center for Bioinformatics, Program of Comparative and Evolutionary Genomics, Faculty of Biological Sciences, Quaid-i-Azam University, 45320, Islamabad, Pakistan.
Shireen H; National Center for Bioinformatics, Program of Comparative and Evolutionary Genomics, Faculty of Biological Sciences, Quaid-i-Azam University, 45320, Islamabad, Pakistan.
Bao Y; National Genomics Data Center & CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, China National Center for Bioinformation, 100101, Beijing, China.; University of Chinese Academy of Sciences, 100101, Beijing, China.
Khan A; Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, 200240, Shanghai, China.; School of Medical and Life Sciences, Sunway University, Sunway City, Malaysia.
Abbasi AA; National Center for Bioinformatics, Program of Comparative and Evolutionary Genomics, Faculty of Biological Sciences, Quaid-i-Azam University, 45320, Islamabad, Pakistan. .; Pokaż więcej
Źródło:: Virology journal [Virol J] 2024 Mar 06; Vol. 21 (1), pp. 55. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/genetics
COVID-19*/epidemiology
Humans ; Pakistan/epidemiology ; Pandemics ; Virulence/genetics ; Amino Acids ; Polyproteins ; Genetic Variation
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Molecular characterization of SARS-CoV-2 Omicron clade and clinical presentation in children.
Autorzy:: Scutari R; Multimodal Laboratory Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Major School in Microbiology and Virology, Campus Bio-Medico University, Rome, Italy.
Fox V; Multimodal Laboratory Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Fini V; Multimodal Laboratory Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Granaglia A; Multimodal Laboratory Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Vittucci AC; Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Smarrazzo A; Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Lancella L; Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Calo' Carducci F; Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Romani L; Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Cursi L; Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Bernaschi P; Microbiology and Diagnostics in Immunology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Russo C; Microbiology and Diagnostics in Immunology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Campana A; Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Bernardi S; Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Villani A; Academic Department of Pediatrics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Perno CF; Multimodal Laboratory Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. .; Microbiology and Diagnostics in Immunology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. .
Alteri C; Multimodal Laboratory Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 04; Vol. 14 (1), pp. 5325. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/genetics
COVID-19*/epidemiology
COVID-19*/genetics
Child ; Humans ; Patient Acuity ; Polymorphism, Single Nucleotide

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: The RdRp genotyping of SARS-CoV-2 isolated from patients with different clinical spectrum of COVID-19.
Autorzy:: Majchrzak M; Institute of Medical Sciences, Jan Kochanowski University, Kielce, Poland.
Madej Ł; Institute of Medical Sciences, Jan Kochanowski University, Kielce, Poland.
Łysek-Gładysińska M; Institute of Biology, Jan Kochanowski University, Kielce, Poland.
Zarębska-Michaluk D; Institute of Medical Sciences, Jan Kochanowski University, Kielce, Poland.
Zegadło K; Institute of Medical Sciences, Jan Kochanowski University, Kielce, Poland.
Dziuba A; Institute of Medical Sciences, Jan Kochanowski University, Kielce, Poland.
Nogal-Nowak K; CDC Poland Sp. z o.o, Kielce, Poland.
Kondziołka W; Scientific and Research Center ARTMEDIK Sp. z o.o, Kielce, Poland.
Sufin I; Meduniv Sp. z o.o, Kielce, Poland.
Myszona-Tarnowska M; Institute of Health Sciences, Jan Kochanowski University, Kielce, Poland.
Jaśkowski M; Specialist Hospital of St. Łukasz, Końskie, Poland.
Kędzierski M; Specialist Hospital of St. Łukasz, Końskie, Poland.
Maciukajć J; Poviat Healthcare Center, Starachowice, Poland.
Matykiewicz J; Institute of Medical Sciences, Jan Kochanowski University, Kielce, Poland.
Głuszek S; Institute of Medical Sciences, Jan Kochanowski University, Kielce, Poland.
Adamus-Białek W; Institute of Medical Sciences, Jan Kochanowski University, Kielce, Poland. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 04; Vol. 24 (1), pp. 281. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*/genetics
COVID-19*/epidemiology
Humans ; Male ; Genotype ; Prospective Studies ; Retrospective Studies ; Outpatients ; RNA-Dependent RNA Polymerase

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants.
Autorzy:: Wang S; College of Veterinary Medicine, International Joint Research Center of National Animal Immunology, Henan Agricultural University, Zhengzhou, 450046, China.
Ding P; School of Life Science, Zhengzhou University, Zhengzhou, 450046, China.
Shen L; College of Veterinary Medicine, International Joint Research Center of National Animal Immunology, Henan Agricultural University, Zhengzhou, 450046, China.
Fan D; College of Veterinary Medicine, International Joint Research Center of National Animal Immunology, Henan Agricultural University, Zhengzhou, 450046, China.
Cheng H; College of Veterinary Medicine, International Joint Research Center of National Animal Immunology, Henan Agricultural University, Zhengzhou, 450046, China.
Huo J; College of Veterinary Medicine, International Joint Research Center of National Animal Immunology, Henan Agricultural University, Zhengzhou, 450046, China.
Wei X; Joint National Laboratory for Antibody Drug Engineering, Henan University, Kaifeng, 475004, China.
He H; College of Veterinary Medicine, International Joint Research Center of National Animal Immunology, Henan Agricultural University, Zhengzhou, 450046, China. .
Zhang G; College of Veterinary Medicine, International Joint Research Center of National Animal Immunology, Henan Agricultural University, Zhengzhou, 450046, China. .; Longhu Laboratory, Zhengzhou, 450046, China. .; School of Advanced Agriculture Sciences, Peking University, Beijing, 100871, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Feb 27; Vol. 22 (1), pp. 76. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:: Journal Article
MeSH Terms:: SARS-CoV-2*
COVID-19*/prevention & control
Animals ; Humans ; Mice ; Nanovaccines ; Biomimetics ; Immunity, Mucosal ; Antibodies, Viral ; Antibodies, Neutralizing
SCR Organism:: SARS-CoV-2 variants

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""SARS-CoV-2"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji